ClinicalTrials.Veeva

Menu

Newborns in Level III Services in Alsace From Mothers With COVID-19 (COVID-Néo)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

COVID-19

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Very little is known about the impact on the newborn of late pre-partum maternal SARS-CoV-2 infection.

Care without separation of the mother and her newborn with continued breastfeeding has been advocated in France and by the WHO but is being debated in some countries.

Assessment of the development of newborns in their first month of life with this strategy associated with close and secure follow-up.

Importance of reporting the potential benefits / risks of this treatment to guide the care of newborns in a persistent epidemic context in a particularly affected region.

Enrollment

50 patients

Sex

All

Ages

1 day to 1 year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newborns born between March 1 and June 30, 2020 to COVID 19
  • From positive mothers in Strasbourg University Hospital or Mulhouse Hospital.
  • Parents' non-opposition to the analysis of hospitalization data for children contained in the medical file

Exclusion criteria

  • Parents' opposition to the analysis of hospitalization data for children contained in the medical file

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems